The “Methyl-CpG Binding Domain Protein 2” Plays a Repressive Role in Relation to the Promoter CpG Content in the Normal Human Cell Line MRC5

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|20|11|1598-1603

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.20, Iss.11, 2014-04, pp. : 1598-1603

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

CpG 7909: PF 3512676, PF-3512676

By Adis International Limited  

Drugs in R&D, Vol. 7, Iss. 5, 2006-01 ,pp. : 312-316

Adis International

Access to resources Recommend Favorite

Immunotherapeutic potential of CpG oligodeoxynucleotides in veterinary species

By Manuja Anju   Manuja Balvinder K.   Kaushik Jyoti   Singha Harisankar   Singh Raj Kumar  

Immunopharmacology and Immunotoxicology, Vol. 35, Iss. 5, 2013-10 ,pp. : 535-544

Informa Healthcare

Access to resources Recommend Favorite

Transcription Factor WT1 and Promoter CpG Hypomethylation Coactivate HOXA10 Expression in Ovarian Cancer

By  

Current Pharmaceutical Design, Vol. 20, Iss. 11, 2014-04 ,pp. : 1647-1654

Bentham Science Publishers

Access to resources Recommend Favorite

Biphasic Lipid Vesicles as a Subcutaneous Delivery System for Protein Antigens and CpG Oligonucleotides

By  

Current Drug Delivery, Vol. 3, Iss. 2, 2006-04 ,pp. : 129-135

Bentham Science Publishers

Access to resources Recommend Favorite

A Review of the Role of CpG Oligodeoxynucleotides as Toll-Like Receptor 9 Agonists in Prophylactic and Therapeutic Vaccine Development in Infectious Diseases

By Gupta Kaveri  

Drugs in R&D, Vol. 9, Iss. 3, 2008-01 ,pp. : 137-145

Adis International

Access to resources Recommend Favorite